Reltecimod sodium
Description
Reltecimod sodium (AB-103 sodium) is an antagonist of the T cell-specific surface glycoprotein CD28 (TP44). Reltecimod sodium has good resistance effects against different bacterial infections, bacterial exotoxins and endotoxins, and ionizing radiation. Reltecimod sodium modulates inflammatory responses by targeting and attenuating, but not inhibiting, the critical CD28/B7-2 costimulatory pathway. Reltecimod sodium can be used in research on necrotizing soft tissue infections (NSTI).
Product Details
| Product Name | Reltecimod sodium |
| Biological activity | Reltecimod sodium (AB-103 sodium) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod sodium has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod sodium modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod sodium can be used to research necrotizing soft-tissue infections (NSTIs). |
| Formula | C46H71N10NaO15S |
| CAS Number | 1943755-99-4 |
| Sequence | {d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala} |
| Sequence Shortening | {d-Ala}-SPMLVAYD-{d-Ala} |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
